Evidence map›Paper›PMID 41699267›Full record

ArticleEuropean journal of human genetics : EJHG2026

Genetic counseling services for hereditary breast and ovarian cancer: patients' experience and satisfaction with different service models.

Ouerdia Haroun, Julie Lapointe, Rachel Guérard, Anne-Sophie Bergeron, Camille Raîche, Jocelyne Chiquette, Karine Bouchard, Marie-Pascale Pomey, Johanne Hébert, Gabrielle Olivier Chevrier and 31 more

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors.

Ouerdia Haroun *Oncology Division, CHU de Québec-Université Laval Research Center, Québec, QC, Canada.
Julie Lapointe *Oncology Division, CHU de Québec-Université Laval Research Center, Québec, QC, Canada.
Rachel GuérardCIUSSS Saguenay Lac-St-Jean, Chicoutimi, QC, Canada.
Anne-Sophie BergeronDepartment of Health Science, Université du Québec à Rimouski, Rimouski, QC, Canada.
Camille RaîcheOncology Division, CHU de Québec-Université Laval Research Center, Québec, QC, Canada.ORCID http://orcid.org/0009-0003-1518-9010
Jocelyne ChiquetteOncology Division, CHU de Québec-Université Laval Research Center, Québec, QC, Canada.
Karine BouchardOncology Division, CHU de Québec-Université Laval Research Center, Québec, QC, Canada.
Marie-Pascale PomeyUniversity of Montreal Hospital Research Centre (CRCHUM), Montréal, QC, Canada.
Johanne HébertCISSS Chaudière-Appalaches Research Center, Lévis, QC, Canada.
Gabrielle Olivier ChevrierOncology Division, CHU de Québec-Université Laval Research Center, Québec, QC, Canada.ORCID http://orcid.org/0009-0008-9301-9144
Philippe LachapelleCHU de Québec-Université Laval, Québec, QC, Canada.
Arian OmeranovicOncology Division, CHU de Québec-Université Laval Research Center, Québec, QC, Canada.ORCID http://orcid.org/0009-0003-2399-3201
Madeleine CôtéCHU de Québec-Université Laval, Québec, QC, Canada.
Lily BoilyCHU de Québec-Université Laval, Québec, QC, Canada.
Carmen BrissonCHU de Québec-Université Laval, Québec, QC, Canada.
Jean GekasCHU de Québec-Université Laval, Québec, QC, Canada.
Tania Cruz-MarinoCIUSSS Saguenay Lac-St-Jean, Chicoutimi, QC, Canada.
Omar TouhamiCIUSSS Saguenay Lac-St-Jean, Chicoutimi, QC, Canada.
Arnaud Blanchet Saint-PierreCISSS Bas St-Laurent, Rimouski, QC, Canada.
Sylvain GagnonCIUSSS Saguenay Lac-St-Jean, Chicoutimi, QC, Canada.
Karine BoisvertCHU de Québec-Université Laval, Québec, QC, Canada.
Claire BrousseauCHU de Québec-Université Laval, Québec, QC, Canada.
Lysanne CastonguayCHU de Québec-Université Laval, Québec, QC, Canada.
Isabelle GosselinCHU de Québec-Université Laval, Québec, QC, Canada.
Marie-Claude RenaudCHU de Québec-Université Laval, Québec, QC, Canada.
Maria-Gabriela Ruiz MangasCHU de Québec-Université Laval, Québec, QC, Canada.
Audrey Paquet-BeaupréCHU de Québec-Université Laval, Québec, QC, Canada.
Marie-Eve BélangerCHU de Québec-Université Laval, Québec, QC, Canada.
Marie-Michelle RacineCISSS Chaudière-Appalaches, Lévis, QC, Canada.
Marie-Claude RoyCIUSSS Saguenay Lac-St-Jean, Chicoutimi, QC, Canada.
Sandra BlanchetteCHU de Québec-Université Laval, Québec, QC, Canada.
Valérie FaucherCIUSSS Saguenay Lac-St-Jean, Chicoutimi, QC, Canada.
Josianne LeblancCIUSSS Saguenay Lac-St-Jean, Chicoutimi, QC, Canada.
Marie-Eve DubeauCIUSSS Saguenay Lac-St-Jean, Chicoutimi, QC, Canada.
Mathias CavailléCHU de Québec-Université Laval, Québec, QC, Canada.
Marie PlanteCHU de Québec-Université Laval, Québec, QC, Canada.
Christine DesbiensCHU de Québec-Université Laval, Québec, QC, Canada.
Martin BeaumontCHU de Québec-Université Laval, Québec, QC, Canada.
Jacques SimardOncology Division, CHU de Québec-Université Laval Research Center, Québec, QC, Canada.ORCID http://orcid.org/0000-0001-6906-3390
Michel DorvalOncology Division, CHU de Québec-Université Laval Research Center, Québec, QC, Canada.ORCID http://orcid.org/0000-0002-3207-8211
Hermann NabiOncology Division, CHU de Québec-Université Laval Research Center, Québec, QC, Canada. Hermann.Nabi@crchudequebec.ulaval.ca.ORCID http://orcid.org/0000-0002-7832-0413

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the context of limited resources and growing demand, patients access genetic testing for hereditary breast and ovarian cancer (HBOC) through various service models, some of which include genetic counseling sessions. This study assessed the impact of these service models and participation in genetic counseling on patients' experiences and satisfaction with the genetic testing process. A total of 501 patients undergoing genetic testing for HBOC completed a 35-item survey, which included the Genetic Counseling Satisfaction Scale, the Decision Regret Scale, and a modified Royal Marsden Satisfaction Questionnaire. Additional information was gathered from the medical records. Descriptive statistics and Fisher's exact tests were employed for the analysis. Four aspects of the genetic testing experience differed between service models and attendance to genetic counseling: i) receipt of informational materials prior to testing, ii) information that additional discussions with the genetic team were possible, iii) clarity regarding the timeline for receiving results, and iv) explanation of how the results would be delivered. The service model and participation in genetic counseling seem to influence patients' experiences with genetic testing for HBOC. However, satisfaction was generally high and decision regret was low across all service models, highlighting the promise of care models designed to enhance accessibility.

Indexed as

Breast NeoplasmsGenetic CounselingOvarian NeoplasmsPatient SatisfactionAdultAgedFemaleGenetic TestingHumansMiddle AgedSurveys and Questionnaires

Identifiers

PMID41699267
PMCPMC13550631

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.